Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Hypertension Clinical criteria: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient, AND Patient must be receiving concurrent antihypertensive therapy.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“Moxonidine has been shown to bind to I1-imidazoline receptors and to a lesser extent α 2-adrenoreceptors. The therapeutic action of moxonidine appears to result from interaction with I1 and α 2-receptors located within the rostral ventrolateral medulla, leading to a reduced activity of sympathetic nerves.”
“The mean plasma elimination half-life of moxonidine is 2.2-2.3 hours, and renal elimination half-life is 2.6-2.8 hours.”
Working under the parallel aged-care framework? Aged-care equivalent →